Science Explorer Back to mapMap
Discussion
Topic · Pathology and Forensic Medicine

Autoimmune Bullous Skin Diseases

Autoimmune Bullous Skin Diseases is a research topic within Pathology and Forensic Medicine. Science Explorer counts 30k research works in it since 1950. 10.2% of them reached the world's top 10% most cited for their field and year.

This cluster of papers focuses on the pathogenesis, diagnosis, and treatment of pemphigoid diseases, particularly bullous pemphigoid and pemphigus vulgaris. It covers topics such as autoantibodies, rituximab therapy, epidemiology, and the use of immunosuppressive therapy including intravenous immunoglobulin. The research also delves into the role of desmoglein in disease pathology and autoimmune mechanisms.

  • Pemphigoid
  • Autoantibodies
  • Rituximab
  • Bullous Pemphigoid
  • Desmoglein
  • Autoimmune
  • Immunosuppressive Therapy
  • Diagnosis
  • Epidemiology
  • Intravenous Immunoglobulin
Research works
30k
fractional, since 1950
In the world top 10%
3.1k
per year above
Top-10% rate
10.2%
share of its works in the world top 10%
Growth, 2018-21 → 2022-25
+12%
the tick is no change
Largest producer
United States
32% of the 10 largest, 2022-now
Autoimmune Bullous Skin Diseases

This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.

Which countries lead Autoimmune Bullous Skin Diseases research?

By volume, the United States and China publish the most (1.3k and 526 works in 2022-now).

By volume, 2022-now

  1. 1 United States 1.3k works
  2. 2 China 526 works
  3. 3 India 519 works
  4. 4 Japan 297 works
  5. 5 Germany 272 works
  6. 6 France 245 works
  7. 7 Spain 232 works
  8. 8 United Kingdom 226 works
  9. 9 Italy 221 works
  10. 10 Brazil 142 works

How concentrated that is

The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.

United States: 32.2%China: 13.3%India: 13.1%Japan: 7.5%6 others listed: 33.8%32%largest
United States1,275 · 32.2%China526 · 13.3%India519 · 13.1%Japan297 · 7.5%6 others listed1,338 · 33.8%

Shares of the rows listed above, not of the whole node.

Which institutions lead Autoimmune Bullous Skin Diseases research?

By volume in 2022-now, Harvard University publishes the most Autoimmune Bullous Skin Diseases research, followed by All India Institute of Medical Sciences and Chinese Academy of Medical Sciences & Peking Union Medical College.

By volume, 2022-now

  1. 1 Harvard UniversityUnited States 51 works
  2. 2 All India Institute of Medical SciencesIndia 42 works
  3. 3 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 34 works
  4. 4 Mayo ClinicUnited States 32 works
  5. 5 University of LübeckGermany 29 works
  6. 6 Post Graduate Institute of Medical Education and ResearchIndia 28 works
  7. 7 Peking UniversityChina 26 works
  8. 8 InsermFrance 26 works
  9. 9 Université Paris CitéFrance 25 works
  10. 10 Assistance Publique – Hôpitaux de ParisFrance 23 works

Who are the leading researchers in Autoimmune Bullous Skin Diseases?

The most-cited researchers publishing on Autoimmune Bullous Skin Diseases include Giuseppe Remuzzi, Gregory Y.H. Lip and Dan J. Stein.

  1. 1 Giuseppe Remuzzi Italy 328k citations
  2. 2 Gregory Y.H. Lip United Kingdom 311k citations
  3. 3 Dan J. Stein South Africa 306k citations
  4. 4 Hagop M. Kantarjian United States 273k citations
  5. 5 Jean‐Louis Vincent Belgium 262k citations
  6. 6 Huanming Yang China 246k citations

Ranked by citations received across their whole record, among researchers with at least three works on this topic.

What are the most cited papers in Autoimmune Bullous Skin Diseases?

The most cited paper in Autoimmune Bullous Skin Diseases is "The 1982 revised criteria for the classification of systemic lupus erythematosus" (Eng M. Tan, Alan S. Cohen, James F. Fries et al., 1982), with 14,664 citations. Next come "Nomenclature for Factors of the HLA System, 2026" (4,206) and "Psoriasis" (2,797).

Most cited papers
#PaperReleasedCitations
1 The 1982 revised criteria for the classification of systemic lupus erythematosus Eng M. Tan, Alan S. Cohen, James F. Fries et al. · Arthritis & Rheumatism Nov 1982 14,664
2 Nomenclature for Factors of the HLA System, 2026 Steven G.E. Marsh et al. · Tissue Antigens Open access 17 Mar 2010 4,206
3 Psoriasis Frank Oliver Nestle, Daniel H. Kaplan, Jonathan Barker · New England Journal of Medicine Open access 29 Jul 2009 2,797
4 Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group Francesco Rodeghiero, Roberto Stasi, Terry Gernsheimer et al. · Blood Open access 12 Nov 2008 2,707
5 Imiquimod-Induced Psoriasis-Like Skin Inflammation in Mice Is Mediated via the IL-23/IL-17 Axis Leslie van der Fits, Sabine Mourits, Jane S.A. Voerman et al. · The Journal of Immunology Open access 21 Apr 2009 2,199
All 100 most cited papers, with filters and sorting

Where is Autoimmune Bullous Skin Diseases research done?

The largest centres of Autoimmune Bullous Skin Diseases research in 2022-now are Beijing (China), Paris (France), London (United Kingdom) and New York (United States). Among places with at least 20 works in it, it is an unusually large share of all research in Lübeck.

Largest cities, 2022-now

  1. 1 BeijingChina 112 works
  2. 2 ParisFrance 82 works
  3. 3 LondonUnited Kingdom 80 works
  4. 4 New YorkUnited States 78 works
  5. 5 TokyoJapan 70 works
  6. 6 MoscowRussia 54 works
  7. 7 TehranIran 54 works
  8. 8 MadridSpain 51 works
  9. 9 ShanghaiChina 49 works
  10. 10 New DelhiIndia 46 works

Where it is the local speciality

  1. LübeckDE · 33.4 works33×
← less than its size predicts1×more →

Location quotient: how much more of its research is in Autoimmune Bullous Skin Diseases than the world average.

See Autoimmune Bullous Skin Diseases on the map

Where is the best place to study Autoimmune Bullous Skin Diseases?

Among universities, judged by research, Harvard University, University of Lübeck and University of Freiburg score highest, combining citation excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.

0%20%40%mean 19.02%fractional works in this field (log) →share of work in the world top 10% →University of FreiburgUniversity of LübeckChinese Academy of M…Harvard University
above the meannear itbelow it

One dot per university in the first ten of the table below, at the default weights. The upper left is the interesting corner: small places doing unusually strong work.

Citation excellenceshare of its work in the world top 10%, 2022-now and all time averaged
40%
Specialisationhow much of its work is in this field, counted up to 10× the world share
10%
Sizeits output in this field, on a log scale
30%
Growthoutput growth, counted from -20% to +20%
10%
Internationalshare of its work with a co-author abroad
10%
Each slider sets a weight; the share it gets of the score is beside it.
#UniversityScoreTop 10%SpecialisationWorksGrowth
1Harvard UniversityUnited States 76.316.8%3.1×51 +10.1%
2University of LübeckGermany 72.420.0%40.1×29 -19.7%
3University of FreiburgGermany 70.030.7%6.9×16 -3.7%
4Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 66.719.8%6.4×34 +60.6%
5Peking UniversityChina 61.318.3%2.5×26 +28.6%
6University of TorontoCanada 59.717.0%1.9×20 +14.9%
7University of MiamiUnited States 59.217.2%6.6×21 +47.3%
8Philipps University of MarburgGermany 58.325.2%8.8×12 0.0%
9UNSW SydneyAustralia 58.012.8%4.1×19 +12.2%
10Cornell UniversityUnited States 56.212.4%3.3×22 +56.4%

Universities only. The score blends citation excellence (40%), size (30%), specialisation (10%), growth (10%), international reach (10%), 2022-now; growth compares 2018-21 with 2022-25 and counts up to +20%, since a jump from a small base is mostly noise.

Every institution in Autoimmune Bullous Skin Diseases, country by country

Is Autoimmune Bullous Skin Diseases research growing?

Output in 2022-2025 was 12% higher than in 2018-2021, peaking in 2023. The fastest-growing topics are Autoimmune Bullous Skin Diseases.

still counting19801990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Autoimmune Bullous Skin Diseases as a percentage of every work published that year, 0.026% in 2024.

still counting0.020%0.040%0.060%Autoimmune Bullous Skin Diseases0.024% in 202519801990200020102020

Fractional works of Autoimmune Bullous Skin Diseases over all fractional works that year. How the balance of science has shifted.

How much of it reaches the world top 10%

Year by year.

still counting5%10%15%Autoimmune Bullous Skin Diseases10.1% in 2025200020102020

Of each year's works in it, the share that reached the world's 10% most cited for their field and year. A field is the world for its own topics, so there is no other line to hold it against.

Which topics inside it are moving

Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.

Discussion

Ask a question or share a note about Autoimmune Bullous Skin Diseases. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.